Dr. Jerold Chun is currently Professor and Senior Vice President of Neuroscience Drug Discovery at Sanford Burnham Prebys Medical Discovery Institute, with over 27 years of experience in academia and industry. He currently leads a team of 25 researchers in the study of genomic mosaicism (DNA sequence variation in brain cells) and lysophospholipid receptor signaling to understand and develop drug treatments for brain diseases such as Alzheimer’s disease, multiple sclerosis, and hydrocephalus. Dr. Chun previously held professorships at The Scripps Research Institute, the University of California San Diego School of Medicine, and also headed the Department of Molecular Neuroscience at Merck Research Laboratories. Among his achievements, he identified the first lysophospholipid receptor (1996), was first to demonstrate genomic mosaicism in the brain (2001) and its
alteration in Alzheimer’s disease (2015). Dr. Chun is a recipient of over a dozen awards, has published ~300 scientific articles, and hold three patents. He received MD and PhD (Neuroscience) degrees through the Medical Scientist Training Program at Stanford University School of Medicine and was a Helen Hay Whitney Fellow at the Whitehead Institute for Biomedical Research/MIT.